Dupont Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-114,759
Closed -$356K 1997
2021
Q4
$356K Sell
114,759
-185
-0.2% -$623 0.01% 925
2021
Q3
$415K Sell
114,944
-16,247
-12% -$61.3K 0.01% 960
2021
Q2
$470K Buy
131,191
+87,012
+197% +$307K 0.01% 1036
2021
Q1
$173K Sell
44,179
-9,061
-17% -$37.4K ﹤0.01% 1292
2020
Q4
$224K Sell
53,240
-3,974
-7% -$15.3K ﹤0.01% 1114
2020
Q3
$213K Sell
57,214
-3,832
-6% -$16.3K ﹤0.01% 1100
2020
Q2
$266K Sell
61,046
-5,450
-8% -$24.5K 0.01% 1015
2020
Q1
$252K Buy
+66,496
New +$327K 0.01% 939

Other funds holding BDSI

Dupont Capital Management's BDSI Position: Q1 2022 in Review

Dupont Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 114,759 shares — an estimated $356K sold.

Dupont Capital Management first reported a position in BDSI in Q1 2020 and held it in 8 quarters. The position peaked at $470K in Q2 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Dupont Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Dupont Capital Management sold 114,759 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $356K.
  • Dupont Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q1 2020 and held it in 8 quarters.
  • Dupont Capital Management's BioDelivery Sciences International, Inc. position peaked at $470K in Q2 2021.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Dupont Capital Management's 13F filing for Q1 2022, filed 27 Apr 2022.